Cargando…

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies

Circulating tumor DNA (ctDNA) is released into circulation (blood) specifically from tumor cells undergoing metabolic secretion, apoptosis, or necrosis, carries tumor-specific genetic or epigenetic alterations. Technologies enabling clinical evaluation of ctDNA continue to advance rapidly and allow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mody, Kabir, Cleary, Sean P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004782/ https://www.ncbi.nlm.nih.gov/pubmed/29942792 http://dx.doi.org/10.3389/fonc.2018.00212

Ejemplares similares

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
por: Qin, Hao, et al.
Publicado: (2022)

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
por: Botrus, Gehan, et al.
Publicado: (2022)

The Rare Malignancy of the Hepatobiliary System: Ampullary Carcinoid Tumor
por: Ozsoy, Mustafa, et al.
Publicado: (2011)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Role of laparoscopy in hepatobiliary malignancies
por: Arumugam, Prabhu, et al.
Publicado: (2016)

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
por: Saoudi González, Nadia, et al.
Publicado: (2022)

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
por: Hugen, Cory M., et al.
Publicado: (2017)

Circulating tumor DNA – A potential aid in the management of chordomas
por: Frederico, Stephen C., et al.
Publicado: (2022)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

Advances and Future Directions in Hepatobiliary Malignancies
por: Taura, Kojiro
Publicado: (2023)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020)

Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction
por: Gabriel, Emmanuel, et al.
Publicado: (2018)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
por: Sun, Li, et al.
Publicado: (2021)

Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers
por: Lin, Shuwen, et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2021)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging
por: Zhang, Ning, et al.
Publicado: (2023)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

Editorial: Immunological characteristics of malignant tumors of the hepatobiliary system and identification of immunotherapy targets
por: Zhang, Qiyao, et al.
Publicado: (2023)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
por: Sánchez-Herrero, Estela, et al.
Publicado: (2022)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
por: Knebel, Franciele H., et al.
Publicado: (2019)

Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future Perspectives
por: Lu, Chang, et al.
Publicado: (2022)

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
por: Trinidad, Eva María, et al.
Publicado: (2023)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Role of serum IgA. Hepatobiliary transport of circulating antigen
Publicado: (1981)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

DWI Combined With Hepatobiliary-Phase Enhanced Imaging Can Better Differentiate Cholangiocarcinoma From Atypical Liver Abscesses
por: Xing, Li-Hong, et al.
Publicado: (2022)

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
por: Kosovec, Juliann E., et al.
Publicado: (2018)

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
por: Shahjehan, Faisal, et al.
Publicado: (2019)

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_udvstglbdr1617k4v1ip0qhpod